[Folic acid in the prevention of neural tube defects]

A Novakov-Mikić1, T Vejnović, L Ivanović

  • 1Klinicki centar, Medicinski fakultet, Novi Sad.

Medicinski Pregled
|April 5, 2000
PubMed

Insights

Neural tube defects (NTD) can be reduced with folic acid supplementation. Women planning pregnancy should take 0.4 mg daily, while those with a history of NTD should take 4 mg daily to prevent recurrence.

Area of Science:

  • Obstetrics and Gynecology
  • Public Health
  • Nutritional Science

Context:

  • Neural tube defects (NTD) are congenital anomalies affecting the brain and spine, with a prevalence of 11.2 per 10,000 live births in continental Europe.
  • Maternal folate levels significantly impact the risk of NTD, with inadequate intake linked to preterm delivery and growth retardation.

Purpose:

  • To review the role of folic acid in preventing neural tube defects.
  • To outline recommended folic acid supplementation strategies for primary and secondary prevention of NTD.

Summary:

  • Folic acid supplementation before conception and during early pregnancy is crucial for preventing NTD.
  • Recommended doses vary: 0.4 mg daily for primary prevention and 4 mg daily for secondary prevention in women with a history of NTD or affected offspring.
  • Educational campaigns are essential to promote awareness and adherence to folic acid supplementation.

Impact:

  • Implementing recommended folic acid supplementation can significantly reduce NTD incidence.
  • Public health initiatives promoting preconception folic acid intake can improve birth outcomes.
  • Further research may explore optimal food fortification strategies and individual risk assessment for NTD prevention.
Abstract

Related Concept Videos

Neurulation01:30

Neurulation

Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the anterior...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...